236 related articles for article (PubMed ID: 32014550)
1. Metabolomic studies of breast cancer in murine models: A review.
Araújo R; Bispo D; Helguero LA; Gil AM
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165713. PubMed ID: 32014550
[TBL] [Abstract][Full Text] [Related]
2. Characterization of triple-negative breast cancer preclinical models provides functional evidence of metastatic progression.
Arroyo-Crespo JJ; Armiñán A; Charbonnier D; Deladriere C; Palomino-Schätzlein M; Lamas-Domingo R; Forteza J; Pineda-Lucena A; Vicent MJ
Int J Cancer; 2019 Oct; 145(8):2267-2281. PubMed ID: 30860605
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry imaging-based metabolomics to visualize the spatially resolved reprogramming of carnitine metabolism in breast cancer.
Sun C; Wang F; Zhang Y; Yu J; Wang X
Theranostics; 2020; 10(16):7070-7082. PubMed ID: 32641979
[TBL] [Abstract][Full Text] [Related]
4. Breast Cancer Metabolomics Using NMR.
Sharma U; Jagannathan NR
Methods Mol Biol; 2019; 2037():195-213. PubMed ID: 31463847
[TBL] [Abstract][Full Text] [Related]
5. Uncovering the metabolomic fingerprint of breast cancer.
Oakman C; Tenori L; Biganzoli L; Santarpia L; Cappadona S; Luchinat C; Di Leo A
Int J Biochem Cell Biol; 2011 Jul; 43(7):1010-20. PubMed ID: 20460168
[TBL] [Abstract][Full Text] [Related]
6. Alterations in arginine and energy metabolism, structural and signalling lipids in metastatic breast cancer in mice detected in plasma by targeted metabolomics and lipidomics.
Kus K; Kij A; Zakrzewska A; Jasztal A; Stojak M; Walczak M; Chlopicki S
Breast Cancer Res; 2018 Dec; 20(1):148. PubMed ID: 30514398
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics in Breast Cancer: Current Status and Perspectives.
Hart CD; Tenori L; Luchinat C; Di Leo A
Adv Exp Med Biol; 2016; 882():217-34. PubMed ID: 26987537
[TBL] [Abstract][Full Text] [Related]
8. A Pilot Study on the Utility of Serum Metabolomics in Neuroblastoma Patients and Xenograft Models.
Beaudry P; Campbell M; Dang NH; Wen J; Blote K; Weljie AM
Pediatr Blood Cancer; 2016 Feb; 63(2):214-20. PubMed ID: 26481088
[TBL] [Abstract][Full Text] [Related]
9. Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer.
Grinde MT; Hilmarsdottir B; Tunset HM; Henriksen IM; Kim J; Haugen MH; Rye MB; Mælandsmo GM; Moestue SA
Breast Cancer Res; 2019 May; 21(1):61. PubMed ID: 31088535
[TBL] [Abstract][Full Text] [Related]
10. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
11. Hormone-Independent Mouse Mammary Adenocarcinomas with Different Metastatic Potential Exhibit Different Metabolic Signatures.
Bispo D; Fabris V; Lamb CA; Lanari C; Helguero LA; Gil AM
Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32867141
[TBL] [Abstract][Full Text] [Related]
12. Metabolic fingerprinting in breast cancer stages through
Suman S; Sharma RK; Kumar V; Sinha N; Shukla Y
J Pharm Biomed Anal; 2018 Oct; 160():38-45. PubMed ID: 30059813
[TBL] [Abstract][Full Text] [Related]
13. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
[TBL] [Abstract][Full Text] [Related]
14. Novel personalized pathway-based metabolomics models reveal key metabolic pathways for breast cancer diagnosis.
Huang S; Chong N; Lewis NE; Jia W; Xie G; Garmire LX
Genome Med; 2016 Mar; 8(1):34. PubMed ID: 27036109
[TBL] [Abstract][Full Text] [Related]
15. (1)H NMR metabolomics identification of markers of hypoxia-induced metabolic shifts in a breast cancer model system.
Weljie AM; Bondareva A; Zang P; Jirik FR
J Biomol NMR; 2011 Apr; 49(3-4):185-93. PubMed ID: 21373841
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Adipose and Luminal Mammary Gland Compartment as Orthotopic Inoculation Sites in a 4T1-Based Immunocompetent Preclinical Model for Triple-Negative Breast Cancer.
Steenbrugge J; Breyne K; Denies S; Dekimpe M; Demeyere K; De Wever O; Vermeulen P; Van Laere S; Sanders NN; Meyer E
J Mammary Gland Biol Neoplasia; 2016 Dec; 21(3-4):113-122. PubMed ID: 27714576
[TBL] [Abstract][Full Text] [Related]
17. NMR-Based Metabolomics in Gallbladder Cancer Research.
Ranjan R; Sinha N
Methods Mol Biol; 2019; 2037():231-241. PubMed ID: 31463849
[TBL] [Abstract][Full Text] [Related]
18. Identification of a serum-detectable metabolomic fingerprint potentially correlated with the presence of micrometastatic disease in early breast cancer patients at varying risks of disease relapse by traditional prognostic methods.
Oakman C; Tenori L; Claudino WM; Cappadona S; Nepi S; Battaglia A; Bernini P; Zafarana E; Saccenti E; Fornier M; Morris PG; Biganzoli L; Luchinat C; Bertini I; Di Leo A
Ann Oncol; 2011 Jun; 22(6):1295-1301. PubMed ID: 21199886
[TBL] [Abstract][Full Text] [Related]
19. Insights into the Chemical Biology of Childhood Embryonal Solid Tumors by NMR-Based Metabolomics.
Quintero Escobar M; Maschietto M; Krepischi ACV; Avramovic N; Tasic L
Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31817982
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
